Graphical Abstract (IMAGE)

IDIBELL-Bellvitge Biomedical Research Institute

Graphical Abstract

Caption

Researchers from IDIBELL have shown that pharmacological and genetic inhibition of RANK/RANKL signaling pathway leads to a significant reduction in recurrences and metastases in breast cancer in a mouse animal model. Their findings suggest that RANK inhibitors currently used in patients with osteoporosis and bone metastases may have potential for treating breast cancer.

Credit

IDIBELL

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.